
Bioventus Inc.: Global leader in orthobiologics, offering advanced medical devices and treatments worldwide.
Founded with a mission to become a global leader in orthobiologics, Bioventus Inc. specializes in the development and distribution of advanced medical devices and treatments aimed at enhancing bone healing and musculoskeletal health. The company's core offerings include ultrasound bone healing devices, osteoarthritis pain treatments, bone fracture healing systems, and portable diagnostic systems. Bioventus serves a global market, providing innovative solutions designed to improve patient outcomes and quality of life.
Bioventus has garnered significant attention and investment from notable figures in the medical device industry. Its achievements include the successful commercialization of products like the EXOGEN Ultrasound Bone Healing System and DUROLANE Hyaluronic Acid Injection. These innovations have positioned Bioventus as a key player in the orthobiologics field, impacting countless patients worldwide by offering non-invasive treatment options that promote faster recovery and pain relief.

Bone Biologics

OsteoNovus
osteonovus.com

Orthofix
orthofix.com

Novum Medical
Zimmer Biomet
zimmerbiomet.com

Osteovantage

RevOrtho
revortho.com

Bone Health Technologies
bonehealthtech.com

Spineology
spineology.com

Atreon Orthopedics
atreonortho.com

BioPoly
biopolyortho.com

Audax Medical
audaxmed.com

Alpha Orthopaedics

Conventus Orthopaedics

SpineOvations
Companies similar to Bioventus include Bone Biologics, OsteoNovus, Orthofix and Novum Medical.
Bioventus was founded in 2012.
Bioventus' headquarters is located in Durham, NC, US.
Bioventus' most recent funding round was for $415M (USD) in April 2022.
As of Apr 26, 2022, Bioventus has raised a total of $427M (USD).
Bioventus has 1,120 employees as of Feb 6, 2024.